Your browser doesn't support javascript.
loading
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung Cancer.
Lim, Sun Min; Fujino, Toshio; Kim, Chulwon; Lee, Gwanghee; Lee, Yong-Hee; Kim, Dong-Wan; Ahn, Jin Seok; Mitsudomi, Tetsuya; Jin, Taiguang; Lee, Sang-Yoon.
Afiliación
  • Lim SM; Department of Internal Medicine, Yonsei University, Seoul, Republic of Korea (South).
  • Fujino T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Kim C; Bridge Biotherapeutics Inc., Seongnam-si, Republic of Korea (South).
  • Lee G; Boostimmune, Inc., Seoul, Republic of Korea (South).
  • Lee YH; Bridge Biotherapeutics Inc., Newton, Massachusetts.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea (South).
  • Ahn JS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea (South).
  • Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Jin T; Bridge Biotherapeutics Inc., Newton, Massachusetts.
  • Lee SY; Bridge Biotherapeutics Inc., Seongnam-si, Republic of Korea (South).
Clin Cancer Res ; 29(16): 3004-3016, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37249619

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article